Baillie Gifford & CO Exscientia PLC Call Options Transaction History
Baillie Gifford & CO
- $126 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding EXAI
# of Institutions
85Shares Held
38.6MCall Options Held
99.7KPut Options Held
191K-
Sb Global Advisers LTD London, X05.68MShares$32.7 Million3.51% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M05.68MShares$32.7 Million0.17% of portfolio
-
Laurion Capital Management LP New York, NY5.41MShares$31.1 Million0.27% of portfolio
-
Platinum Investment Management LTD Sydney Australia 2000, C33.95MShares$22.7 Million0.93% of portfolio
-
Woodline Partners LP San Francisco, CA1.66MShares$9.52 Million0.09% of portfolio
About Exscientia plc
- Ticker EXAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 122,461,000
- Market Cap $704M
- Description
- Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on s...